Quick Answer
Bio Essence Corp reported Stockholders Equity of -$2.07 million for the year ending 2025.
- Bio Essence Corp showed an increase of +30.2% in Stockholders Equity from 2024 to 2025.
- This data is from Bio Essence Corp's annual report (Form 10-K), filed with the SEC on March 27, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2020: -$1.30 million | Q2 2020: -$1.49 million | Q3 2020: -$1.69 million | Q1 2021: -$1.99 million | Q2 2021: -$2.16 million | Q3 2021: -$2.34 million | Q1 2022: -$2.66 million | Q2 2022: -$2.83 million | Q3 2022: -$3.03 million | Q1 2023: -$3.42 million | Q2 2023: -$1.15 million | Q3 2023: -$1.47 million | Q1 2024: -$1.53 million | Q2 2024: -$1.74 million | Q3 2024: -$2.94 million | Q1 2025: -$3.17 million | Q2 2025: -$3.11 million | Q3 2025: -$3.10 million.
- Over the full 7 years of available data (2019 to 2025), Bio Essence Corp's Stockholders Equity has declined by 91.0%.
- Historical annual values: Fiscal year 2025: -$2.07 million | Fiscal year 2024: -$2.97 million | Fiscal year 2023: -$1.66 million | Fiscal year 2022: -$3.24 million | Fiscal year 2021: -$2.43 million | Fiscal year 2020: -$1.78 million | Fiscal year 2019: -$1.09 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: